0000899243-20-003809.txt : 20200210
0000899243-20-003809.hdr.sgml : 20200210
20200210161323
ACCESSION NUMBER: 0000899243-20-003809
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200210
FILED AS OF DATE: 20200210
DATE AS OF CHANGE: 20200210
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lynton Michael
CENTRAL INDEX KEY: 0001606115
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39206
FILM NUMBER: 20592049
MAIL ADDRESS:
STREET 1: 2000 AVENUE OF THE STARS 12TH FL
CITY: LOS ANGELES
STATE: CA
ZIP: 90067
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Schrodinger, Inc.
CENTRAL INDEX KEY: 0001490978
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 954284541
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 120 WEST 45TH STREET
STREET 2: 17TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10036
BUSINESS PHONE: 503-299-1150
MAIL ADDRESS:
STREET 1: 120 WEST 45TH STREET
STREET 2: 17TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10036
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-02-10
0
0001490978
Schrodinger, Inc.
SDGR
0001606115
Lynton Michael
C/O SCHRODINGER, INC.,
120 WEST 45TH STREET, 17TH FLOOR
NEW YORK
NY
10036
1
0
0
0
Stock Option (right to buy)
17.00
2020-02-10
4
A
0
12909
0.00
A
2030-02-04
Common Stock
12909
12909
D
The option was granted on February 5, 2020. The commencement of vesting was contingent upon the closing of the Issuer's initial public offering, which occurred on February 10, 2020. The shares underlying the option are scheduled to vest in full on February 5, 2021.
/s/ Yvonne Tran, as attorney-in-fact for Michael Lynton
2020-02-10